Adherex Announces ASCO Abstract of ADH-1 in Melanoma

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - May 19, 2008) - Adherex Technologies Inc. (AMEX:ADH)(TSX:AHX), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today the publication of an abstract on the phase I/II study of ADH-1 in combination... [read full story]                    

Add Comment
There are also 5 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies